According to Figure 1B, the upregulation of WDR43 expression has been detected through diverse forms of cancer, involving cholangiocarcinoma, esophageal carcinoma (ESCA), lung squamous cell carcinoma (LUSC), colon adenocarcinoma (COAD), lung adenocarcinoma (LUAD), head and neck squamous cell carcinoma (HNSC), uterine corpus endometrial carcinoma (UCEC), LIHC, stomach adenocarcinoma (STAD), and rectum adenocarcinoma (READ) (all P < .001), kidney renal clear cell carcinoma (KIRC) (P < .01), bladder urothelial carcinoma (BLCA) and glioblastoma (GBM) (P < .05). The gene discussed is WDR43; the disease is bladder transitional cell carcinoma.